183814-19-9

Basic information

• Product Name: ((1S,2R,3S,4R)-1-Benzyl-4-benzyloxycarbonylamino-2,3-dihydroxy-5-phenyl-pentyl)-carbamic acid benzyl ester
• Synonyms: ((1S,2R,3S,4R)-1-Benzyl-4-benzyloxycarbonylamino-2,3-dihydroxy-5-phenyl-pentyl)-carbamic acid benzyl ester
• CAS NO: 183814-19-9
• Molecular Weight: 568.67
• Mol File: 183814-19-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ((1S,2R,3S,4R)-1-Benzyl-4-benzyloxycarbonylamino-2,3-dihydroxy-5-phenyl-pentyl)-carbamic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: ((1S,2R,3S,4R)-1-Benzyl-4-benzyloxycarbonylamino-2,3-dihydroxy-5-phenyl-pentyl)-carbamic acid benzyl ester(183814-19-9)
• EPA Substance Registry System: ((1S,2R,3S,4R)-1-Benzyl-4-benzyloxycarbonylamino-2,3-dihydroxy-5-phenyl-pentyl)-carbamic acid benzyl ester(183814-19-9)

Safety Data

• Hazardous Substances Data: 183814-19-9(Hazardous Substances Data)

Upstream product

• 58917-85-4 N-(benzyloxycarbonyl)-D-phenylalaninol 
• 63219-70-5 N-(benzyloxycarbonyl)-D-phenylalaninal 

Downstream Products

• 153181-25-0 (4R,5S,6S,7R)-hexahydro-5,6-bis(2-methoxyethoxymethoxy)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one 
• 1053243-89-2 C₄₃H₄₈N₄O₇ 
• 1053252-82-6 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-trifluoromethyl-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1053711-24-2 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-benzyloxy-benzyl)-5,6-bis-(2-methoxy-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1054660-74-0 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-nitro-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1054639-78-9 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-naphthalen-2-ylmethyl-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1053623-63-4 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(2-methoxy-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1054650-85-9 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-methoxy-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1053727-69-7 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(2-chloro-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 186040-83-5 (4R-(4α,5α,6β,7β))-3,3'-{[tetrahydro-5,6-bis[(2-methoxyethoxy)methoxy]-2-oxo-4,7-bis(phenylmethyl)-1H-1,3-diazepine-1,3(2H)-diyl]bis(methylene)}bis(benzonitrile) 
• 1053244-86-2 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-bromo-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1053608-75-5 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-chloro-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 
• 1053255-44-9 (4R,5S,6S,7R)-4,7-Dibenzyl-1,3-bis-(3-iodo-benzyl)-5,6-bis-(2-trimethylsilanyl-ethoxymethoxy)-[1,3]diazepan-2-one 

Relevant articles and documents

Cyclic HIV protease inhibitors: Synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas

High-resolution X-ray structures of the complexes of HIV-1 protease (HIV-1PR) with peptidomimetic inhibitors reveal the presence of a structural water molecule which is hydrogen bonded to both the mobile flaps of the enzyme and the two carbonyls flanking